vimarsana.com
  1. Home
  2. Live Updates
  3. Rodger Novak - Breaking News

Rodger Novak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

No tolerance for failure : An oral history of the first CRISPR medicine

BioPharma

United statesStanford universityNew yorkNessan berminghamTirtha chakrabortyShaun foySimeon georgeStuart arbuckleSam kulkarniJerel davisFeng zhangRodger novakEmmanuelle charpentierHaydar frangoulStuart orkinRachel haurwitz

Sickle Cell Disease Gene-Editing Treatments Unaffordable for Many

Sickle Cell Disease Gene-Editing Treatments Unaffordable for Many
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesMelissa crearyRodger novakSickle cell disease association of americaMedicaid servicesDrug administrationCenters for medicareUm school of public healthPublic healthSickle cell disease association

Is CRISPR Therapeutics the Best Gene-Editing Stock?

The biotech's first-mover advantage bodes well for its long-term prospects.

Shaun foyEmmanuelle charpentierRodger novakDrug administrationEuropean unionRegeneron pharmaceuticalsEuropean medicines agencyRegulatory agencyVertex pharmaceuticalsImage sourceBeam therapeuticsEditas medicineBluebird bio

A decade later, biotech s CRISPR revolution is still going strong

BioPharma

San francisco bayUnited statesStanford universityFeng zhangEli lillyKeith joungDavid liuRodger novakTrevor martinEmmanuelle charpentierJennifer doudnaFyodor urnovLucas harringtonShaun foyJohn leonardGeorge church

Startup AIRNA emerges from stealth to bring RNA editing to a rare disease

BioPharma

United statesUnited kingdomKris elverumRodger novakFast track initiativeStanford universityWave life sciencesDive briefDiagon therapeuticsRubius therapeuticsTurnstone biologicsArch venture partners

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.